CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jiangsu Sihuan Bioengineering Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jiangsu Sihuan Bioengineering Co Ltd
No.10
No.10 Dingshan Road
Phone: +86 51086408558p:+86 51086408558 WUXI, JNG  214434  China Ticker: 000518000518

Business Summary
Jiangsu Sihuan Bioengineering Co Ltd is a China-based company principally engaged in the production and sales of biopharmaceutical products and landscaping engineering. The Company operates its businesses through three segments. The Pharmaceutical segment is mainly engaged in the production and sales of injections and medicines. The Forestry segment is mainly engaged in greening construction and forestry sales. The Others segment is mainly engaged in leasing and other businesses. The Company's main products include Delusheng (recombinant human interleukin-2 for injection), Xindelusheng (recombinant human interleukin-2 injection) and others. The Company's products are mainly used for the treatment of renal cancer, malignant melanoma, and cancerous pleural and abdominal effusions. The Company mainly operates its businesses in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202512/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Financial Officer JieZhao 30 4/17/2024 4/17/2024
General Manager, Director LongChen 36 5/16/2025 5/16/2025
Deputy General Manager, Secretary of the Board YangZhou 38 5/16/2025
5 additional Officers and Directors records available in full report.

Business Names
Business Name
000518
Jiangsu Sihuan Bioengineering Co., Ltd

General Information
Number of Employees: 277 (As of 12/31/2024)
Outstanding Shares: 1,029,556,222 (As of 3/31/2025)
Shareholders: 99,399
Stock Exchange: SHE
Fax Number: +86 51086408558


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 23, 2025